Tag: DRAP

  • محتسب کی مداخلت پر 77 فارما کمپنیوں کو 38 کروڑ 70 لاکھ روپے کے واجبات مل گئے

    محتسب کی مداخلت پر 77 فارما کمپنیوں کو 38 کروڑ 70 لاکھ روپے کے واجبات مل گئے

    24 نیوز کے مطابق وفاقی محتسب کی مداخلت پر 77 دوا ساز کمپنیوں کو طویل عرصے سے زیر التوا 38 کروڑ 70 لاکھ روپے کے واجبات مل گئے ہیں۔

    تفصیلات کے مطابق 77 کمپنیاں کئی برس سے اپنے واجبات کی ادائیگی کی منتظر تھیں۔ وفاقی محتسب نے معاملے کا نوٹس لیا اور ڈرگ ریگولیٹری اتھارٹی آف پاکستان (ڈریپ) کو ہدایات جاری کیں، جس کے بعد زیر التوا ادائیگیاں جاری کر دی گئیں۔

    وفاقی محتسب اعجاز احمد قریشی نے ڈریپ کو ہدایت کی کہ مسئلہ تین ماہ کے اندر حل کیا جائے، جس کے بعد واجبات ادا کر دیے گئے۔

    اعجاز احمد قریشی کا کہنا تھا کہ دوا ساز کمپنیوں کو واجبات کی بروقت ادائیگی ادویات کی بلا تعطل فراہمی کے لیے ضروری ہے۔

    تحقیقات سے معلوم ہوا کہ واجبات کئی برس سے زیر التوا تھے اور کئی کمپنیاں 50 لاکھ روپے یا اس سے زائد کی ادائیگی کی منتظر تھیں۔

  • 77 Pharma Firms Get Rs387m Dues After Ombudsman Steps In

    77 Pharma Firms Get Rs387m Dues After Ombudsman Steps In

    Seventy-seven pharmaceutical companies have received long-pending dues amounting to Rs387 million after the intervention of the Federal Ombudsman, 24NewsHD reported.

    According to details, the 77 companies had been awaiting the payment of their dues for the past several years. The Federal Ombudsman took notice of the matter and issued directives to the Drug Regulatory Authority of Pakistan (DRAP), after which the outstanding payments were released.

    Federal Ombudsman Ejaz Ahmad Qureshi directed DRAP to resolve the issue within three months, following which the dues were cleared.

    Ejaz Ahmad Qureshi said that timely payment of dues to pharmaceutical companies is essential for the uninterrupted supply of medicines.

    Investigation revealed that the dues had been pending for several years, with many companies awaiting payments of Rs5 million or more.

  • DRAP Warns Parents Against Fake Hexaxim Vaccine for Babies

    DRAP Warns Parents Against Fake Hexaxim Vaccine for Babies

    The Drug Regulatory Authority of Pakistan (DRAP) has warned parents never to give a fake version of the children’s vaccine Hexaxim to children under one year of age, after declaring a batch of the vaccine available in the market to be fake.

    According to DRAP’s Rapid Alert 53, issued on 12 November 2026, the fake supply concerns Hexaxim vials carrying batch number X3H421VA and sold under the name of the multinational company Sanofi. The authority has imposed an immediate ban on the purchase, sale and use of this batch.

    Hexaxim is a six-in-one vaccine that protects children under one year of age against diphtheria, tetanus, whooping cough, polio, hepatitis B and Haemophilus influenzae type b (Hib). DRAP said the genuine Hexaxim registered in Pakistan is supplied only as a pre-filled syringe, and the vial form found in the market is not registered at all.

    Distributor flagged the fake supply

    The matter came to light when Hoechst Pakistan, the company that distributes Sanofi’s Hexaxim in Pakistan, informed DRAP about the supply of the vaccine in vial form. Hoechst Pakistan clearly disassociated itself from the vial packing of the fake vaccine.

    DRAP has issued strict instructions to all provinces to take measures on an emergency basis against the fake medicine trade. Provincial drug authorities and field force teams have been ordered to raid the market immediately and seize the fake batch wherever it is found.

    Fake and substandard medicines are a long-running problem in Pakistan and across the developing world. The World Health Organization estimates that about one in ten medical products in low- and middle-income countries is substandard or falsified, and vaccines and injections are among the products most often targeted. DRAP issues rapid alerts when a fake product is detected so that it can be pulled from the market before it reaches patients.

    The authority has also advised that if any child shows adverse effects after receiving this vaccine, the matter should be reported immediately to the National Pharmacovigilance Centre. Parents are advised to check that the vaccine given to their child is the registered pre-filled syringe form, and to get their children vaccinated only from trusted health facilities. Anyone who has already received a Hexaxim vial, or who is unsure about a dose already given, should speak to their child’s doctor and ask whether a repeat dose is needed.